A DTaP–IPV//PRP∼ T vaccine (Pentaxim™): a review of 16 years' clinical experience
SA Plotkin, J Liese, SA Madhi, E Ortiz - Expert Review of Vaccines, 2011 - Taylor & Francis
… This article provides an overview of the worldwide clinical experience with an established
DTaP–IPV//PRP∼T combination vaccine, Pentaxim™ (Sanofi Pasteur; marketed as Pentavac…
DTaP–IPV//PRP∼T combination vaccine, Pentaxim™ (Sanofi Pasteur; marketed as Pentavac…
A randomized, controlled study of DTaP-IPV-HB-PRP-T, a fully liquid hexavalent vaccine, administered in a 3-, 5-and 11-to 12-month schedule
T Vesikari, SA Silfverdal, E Jordanov… - The Pediatric Infectious …, 2017 - journals.lww.com
… clinical experience and broader use. The present study was therefore conducted in Finland
and Sweden using the 3-, 5-, 11- to 12-month schedule, in comparison to Infanrix hexa and …
and Sweden using the 3-, 5-, 11- to 12-month schedule, in comparison to Infanrix hexa and …
[HTML][HTML] Immunogenicity and safety study of a new DTaP–IPV–Hep B–PRP-T combined vaccine compared to a licensed DTaP–IPV–Hep B//PRP-T comparator, both …
P Kosalaraksa, U Thisyakorn, S Benjaponpitak… - International Journal of …, 2011 - Elsevier
… following reasons: participation in another clinical trial in the 4 weeks prior to the first
vaccination in our trial, or planned participation in another clinical trial during the planned period of …
vaccination in our trial, or planned participation in another clinical trial during the planned period of …
Safety and immunogenicity of an investigational fully liquid hexavalent DTaP-IPV-Hep B-PRP-T vaccine at two, four and six months of age compared with licensed …
M Macías, CF Lanata, B Zambrano, AI Gil… - The Pediatric …, 2012 - journals.lww.com
Objective: This trial assessed the safety of a fully liquid investigational hexavalent DTaP-IPV-Hep
B-PRP-T vaccine containing 10 μg Hansenula polymorpha–derived recombinant …
B-PRP-T vaccine containing 10 μg Hansenula polymorpha–derived recombinant …
Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants
T Vesikari, R Borrow, X Da Costa, P Richard, C Eymin… - Vaccine, 2017 - Elsevier
… DTaP-IPV-HB-PRP-T or hexavalent vaccines are indicated … of 1:1 to receive DTaP-IPV-HB-PRP-T
vaccine at two, three … after the third dose of DTaP-IPV-HB-PRP-T vaccine was 97.5% […
vaccine at two, three … after the third dose of DTaP-IPV-HB-PRP-T vaccine was 97.5% […
A fully liquid DTaP-IPV-HB-PRP-T hexavalent vaccine for primaryand booster vaccination of healthy Turkish infants and toddlers
M Ceyhan, I Yildirim, H Tezer… - Turkish Journal of …, 2017 - journals.tubitak.gov.tr
… based on the extensive experience with the DTaP-IPV-HB-PRP-T vaccine: … clinical studies
of DTaP-IPV-HB-PRP-T, conducted over four continents, have consistently shown no clinically …
of DTaP-IPV-HB-PRP-T, conducted over four continents, have consistently shown no clinically …
[HTML][HTML] Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers
T Vesikari, R Borrow, X Da Costa, S Thomas, C Eymin… - Vaccine, 2018 - Elsevier
… The immunogenicity assessments used for the DTaP-IPV-HB-PRP-T vaccine were consistent
with those used during the clinical development plan with regards to the assays used, the …
with those used during the clinical development plan with regards to the assays used, the …
… -Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T …
M Tregnaghi, B Zambrano… - The Pediatric Infectious …, 2012 - journals.lww.com
… A booster dose of DTaP-IPV//PRP-T vaccine (Pentaxim) was … either the investigational
DTaP-IPV-HepB-PRP-T vaccine or … another clinical trial or any involvement in another clinical trial …
DTaP-IPV-HepB-PRP-T vaccine or … another clinical trial or any involvement in another clinical trial …
[HTML][HTML] … and safety of a combined DTaP-IPV//Hib vaccine compared with individual DTaP-IPV and Hib (PRP~ T) vaccines: a randomized clinical trial in South Korean …
JH Kang, HJ Lee, KH Kim, SH Oh… - Journal of Korean …, 2016 - synapse.koreamed.org
… -IPV//Hib pentavalent combination vaccine (Pentaxim™) compared with licensed DTaP-IPV
and Hib (PRP~… separate DTaP-IPV and Hib vaccines (n = 206) or the pentavalent DTaP-IPV//…
and Hib (PRP~… separate DTaP-IPV and Hib vaccines (n = 206) or the pentavalent DTaP-IPV//…
[PDF][PDF] Immunogenicity and safety of a fully liquid DTaP-IPV-Hep B-PRP-T vaccine at 2-4-6 months of age in Peru
C Lanata, B Zambrano, L Ecker, I Amemiya, A Gil… - J Vaccines …, 2012 - academia.edu
Objectives: To assess the immunogenicity and safety of a new candidate, fully liquid, hexavalent
DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim™, an AcXim family vaccine) compared to a …
DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim™, an AcXim family vaccine) compared to a …